Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $5.16 Million - $6.04 Million
-21,228 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $237,913 - $358,119
-1,007 Reduced 4.53%
21,228 $5.2 Million
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $281,185 - $324,664
-1,062 Reduced 4.56%
22,235 $6.31 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $633,199 - $838,562
-2,448 Reduced 9.51%
23,297 $6.23 Million
Q4 2019

Feb 19, 2020

SELL
$220.06 - $304.07 $117,291 - $162,069
-533 Reduced 2.03%
25,745 $7.64 Million
Q3 2019

Nov 05, 2019

SELL
$217.44 - $243.88 $298,980 - $335,335
-1,375 Reduced 4.97%
26,278 $6.12 Million
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $89,908 - $99,105
-410 Reduced 1.46%
27,653 $6.47 Million
Q1 2019

May 07, 2019

SELL
$216.71 - $338.96 $74,331 - $116,263
-343 Reduced 1.21%
28,063 $6.63 Million
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $24,229 - $30,689
87 Added 0.31%
28,406 $8.55 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $377,453 - $493,605
-1,286 Reduced 4.34%
28,319 $10 Million
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $34,765 - $41,432
135 Added 0.46%
29,605 $8.59 Million
Q1 2018

May 14, 2018

BUY
$260.13 - $367.91 $4,942 - $6,990
19 Added 0.06%
29,470 $8.07 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $30,764 - $34,458
100 Added 0.34%
29,451 $9.38 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $8.25 Million - $9.68 Million
29,351
29,351 $9.19 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.